Inflammatory and Imaging-based Predictors of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation Using Electroanatomical Mapping – the INFLAMAP Study

1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006:114:e257-e354.Search in Google Scholar

2. Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012;142:1489-1498.10.1378/chest.11-2888Search in Google Scholar

3. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739-745.10.1016/S0140-6736(09)60443-8Search in Google Scholar

4. Haïssaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.10.1056/NEJM1998090333910039725923Search in Google Scholar

5. Benedek I, Hintea T, Toganel R. Myocardial fibers in pulmonary veins – possible compensatory factor in dilated cardiomyopathy. Romanian Journal of Internal Medicine. 1998;36:175-183.Search in Google Scholar

6. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.10.1161/01.CIR.92.7.19547671380Search in Google Scholar

7. Paulus K, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-2962.10.1093/eurheartj/ehw21027567408Search in Google Scholar

8. Ganesan AN, Shipp NJ, Brooks AG, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2:e004549.10.1161/JAHA.112.004549364728623537812Search in Google Scholar

9. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2:349-361.10.1161/CIRCEP.108.82478919808490Search in Google Scholar

10. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002:347:305-313.10.1056/NEJMoa02024512151467Search in Google Scholar

11. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335-2345.10.1016/j.jacc.2014.02.55524613319Search in Google Scholar

12. Tan AY, Zimetbaum P. Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol. 2011;57:625-629.10.1097/FJC.0b013e3182073c78411365421266918Search in Google Scholar

13. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E4. Cardiac Fibrosis in Patients With Atrial Fibrillation. JACC. 2015;66:943-959.10.1016/j.jacc.2015.06.131326293766Search in Google Scholar

14. Pinto T, Oliveira M, Ramos R, et al. Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation. J Interv Card Electrophysiol. 2017;49:165-171.10.1007/s10840-017-0256-428567579Search in Google Scholar

15. Luong C, Thompson DJ, Bennett M, et al. Right Atrial Volume Is Superior to Left Atrial Volume for Prediction of Atrial Fibrillation Recurrence After Direct Current Cardioversion. Can J Cardiol. 2015;31:29-35.10.1016/j.cjca.2014.10.00925547547Search in Google Scholar

16. Njoku A, Kannabhiran M, Arora R, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace. 2018;20:33-42.10.1093/europace/eux01328444307Search in Google Scholar

17. Tong L, Guangping L, Lijian L, Korantzopoulos P. Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion. J Am Coll Cardiol. 2007;49:1642-1648.10.1016/j.jacc.2006.12.04217433956Search in Google Scholar

18. den Uijl DW, Delgado V, Tops LF, et al. Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation. Am Heart J. 2011;161:197-203.10.1016/j.ahj.2010.09.03121167354Search in Google Scholar

19. Xiangdong X, Yongqing T. Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis. Braz J Cardiovasc Surg. 2017;32:530-535.Search in Google Scholar

20. Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB. Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. Am J Cardiol. 2006;97:1213-1219.10.1016/j.amjcard.2005.11.04016616028Search in Google Scholar

21. Marchese P, Bursi F, Delle Donne G, et al. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr. 2011;12:214-221.10.1093/ejechocard/jeq17621149290Search in Google Scholar

22. Marchese P, Malavasi V, Rossi L, et al. Indexed left atrial volume is superior to left atrial diameter in predicting nonvalvular atrial fibrillation recurrence after successful cardioversion: a prospective study. Echocardiography. 2012;29:276-284.10.1111/j.1540-8175.2011.01580.x22098539Search in Google Scholar

23. D’Ascenzo F, Corleto A, Biondi-Zoccai G, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol. 2013;167:1984-1999.10.1016/j.ijcard.2012.05.00822626840Search in Google Scholar

24. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004:292:2471-2477.10.1001/jama.292.20.247115562125Search in Google Scholar

25. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity – results of a meta-analysis. Am Heart J. 2008:155:310-315.10.1016/j.ahj.2007.10.00418215602Search in Google Scholar

26. Thanassoulis G, Massaro JM, O’Donnell CJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345-350.10.1161/CIRCEP.109.912055295385520558845Search in Google Scholar

27. Gaeta M, Bandera F, Tassinari F, et al. Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis. Europace. 2017;19:747-752.10.1093/europace/euw39828087595Search in Google Scholar

28. Al-Rawahi M, Proietti R, Thanassoulis G. Pericardial fat and atrial fibrillation: Epidemiology, mechanisms, and interventions. Int J Cardiol. 2015;195:98-103.10.1016/j.ijcard.2015.05.12926025867Search in Google Scholar

29. Batal O, Schoenhagen P, Shao M, et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:230-236.10.1161/CIRCEP.110.957241297456620504944Search in Google Scholar

30. Greif M, von Ziegler F, Wakili R, et al. Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol. 2013;102:555–562.10.1007/s00392-013-0566-123584714Search in Google Scholar

31. Chekakie MO, Akar JG. Epicardial Fat and Atrial Fibrillation: A Review. J Atr Fibrillation. 2012;4:483.Search in Google Scholar

32. Chekakie MO, Welles CC, Metoyer R, et al. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol. 2010;56:784-788.10.1016/j.jacc.2010.03.07120797492Search in Google Scholar

33. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536-543.10.1038/ncpcardio031916186852Search in Google Scholar

34. Sawaya SE, Rajawat YS, Rami TG, et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol. 2007;292:H1561-H1567.10.1152/ajpheart.00285.200617122196Search in Google Scholar

35. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J. 2008;155:303-309.10.1016/j.ahj.2007.09.006224736618215601Search in Google Scholar

36. Tselentakis EV, Woodford E, Chandy J, Gaudette GR, Saltman AE. Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. J Surg Res. 2006;135:68-75.10.1016/j.jss.2006.03.02416650868Search in Google Scholar

37. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.10.1161/hc4901.10176011739301Search in Google Scholar

38. Malouf JF, Kanagala R, Al Atawi FO, et al. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol. 2005;46:1284-1287.10.1016/j.jacc.2005.06.05316198844Search in Google Scholar

39. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010.10.1161/01.CIR.0000103131.70301.4F14623805Search in Google Scholar

40. Rotter M, Jais P, Vergnes MC, et al. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation. J Am Coll Cardiol. 2006;47:1231-1233.10.1016/j.jacc.2005.12.03816545659Search in Google Scholar

41. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907-917.10.1016/j.ahj.2007.03.01917540190Search in Google Scholar

42. Verheule S, Sato T, Everett TT, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res. 2004;94:1458-1465.10.1161/01.RES.0000129579.59664.9d212910215117823Search in Google Scholar

43. Konishi M, Sugiyama S, Sugamura K, et al. Accumulation of pericardial fat correlates with left ventricular diastolic dysfunction in patients with normal ejection fraction. J Cardiol. 2012;59:344-351.10.1016/j.jjcc.2012.01.00622365950Search in Google Scholar

44. Palazzuoli A, Beltrami M, Ruocco G, et al. The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction. Scientific World Journal. 2013;2013:784670.10.1155/2013/784670380444724191143Search in Google Scholar

45. Mottram PM, Leano R, Marwick TH. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol. 2003;92:1434-1438.10.1016/j.amjcard.2003.08.05314675580Search in Google Scholar

46. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105:595-601.10.1161/hc0502.10301011827925Search in Google Scholar

47. Ellinor PT, Low AF, Patton KK, Shea MA, Macrae CA. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol. 2005;45:82-86.10.1016/j.jacc.2004.09.04515629379Search in Google Scholar

48. Wozakowska-Kaplon, B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol. 2004;93:1555-1558.10.1016/j.amjcard.2004.03.01315194036Search in Google Scholar

49. Bartkowiak, R, Wozakowska-Kapłon B, Janiszewska G. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion. Kardiol Pol. 2012;68:48-54.Search in Google Scholar

50. Yamada T, Murakami Y, Okada T, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. Am J Cardiol. 2006;97:1741-1744.10.1016/j.amjcard.2005.12.07116765125Search in Google Scholar